Mid-Afternoon Market Update: Dow Edges Higher; Sequential Brands Shares Spike Higher

Toward the end of trading Wednesday, the Dow traded up 0.08% to 29,846.44 while the NASDAQ fell 0.09% to 12,343.79. The S&P also rose, gaining 0.13% to 3,667.11.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 13,726,300 cases with around 270,690 deaths. India confirmed a total of at least 9,499,410 confirmed cases and 138,120 deaths, while Brazil reported over 6,386,780 COVID-19 cases with 173,810 deaths. In total, there were at least 63,995,700 cases of COVID-19 worldwide with over 1,483,220 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors


Energy shares climbed 3.6% on Wednesday. Meanwhile, top gainers in the sector included Energy Fuels Inc. UUUU, up 14%, and Kosmos Energy Ltd. KOS, up 12%.


In trading on Wednesday, materials shares fell 1.3%.


Top Headline

Pfizer Inc PFE and its German partner BioNTech SE BNTX said Wednesday they have received regulatory approval in the United Kingdom for their COVID-19 vaccine..

The go-ahead from the Medicines and Healthcare Products Regulatory Agency (MHRA) means the U.K. has become the first country to approve a COVID-19 vaccine on an emergency basis ahead of the United States and the European Union.

 


Equities Trading UP


Sequential Brands Group, Inc. SQBG shares shot up 24% to $11.69 after the company announced relaunch of broad review of strategic alternatives.


Shares of Tredegar Corporation TG got a boost, shooting 31% to $21.66 after the company declared a special dividend of $5.97 per share.


Kingsway Financial Services Inc. KFS shares were also up, gaining 24% to $3.7668 Kingsway Financial Services reported the closing of its acquisition of PWI Holdings, Inc.

 


Equities Trading DOWN

Ovid Therapeutics Inc. OVID shares tumbled 55% to $2.9650 after the company announced topline results from the Phase 3 NEPTUNE study of OV101 for the treatment of Angelman syndrome, showing the study did not meet the primary endpoint of change in overall score on the Clinical Global Impression-Improvement-Angelman syndrome. Citigroup downgraded Ovid Therapeutics from Buy to Neutral and lowered the price target from$10 to $4.

Shares of Auris Medical Holding Ltd. EARS were down 35% to $3.41 after the company priced an $8 million offering at $4 per share.


ReneSola Ltd SOL was down, falling 21% to $6.24 after the company reported downbeat quarterly sales..

 


Commodities


In commodity news, oil traded up 1.7% to $45.29, while gold traded up 0.7% to $1,831.70.


Silver traded up 0.1% Wednesday to $24.095 while copper rose 0.1% to $3.4905.


Euro zone

European shares closed mixed today. The eurozone’s STOXX 600 fell 0.05%, the Spanish Ibex Index rose 0.98%, while Italy’s FTSE MIB Index declined 0.58%. Meanwhile, the German DAX 30 declined 0.52%, French CAC 40 rose 0.02% and London’s FTSE 100 gained 1.23%.

Retail sales in Germany climbed 2.6% in October versus a revised 1.9% decline in September.

 

Economics


US private sector created 307,000 jobs in November, the ADP reported. However, analysts were expecting an addition of 410,000 jobs.


US crude-oil inventories declined 700,000 barrels last week, the Energy Information Administration said.


The Federal Open Market Committee released its latest Beige Book report.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!